SMR enters the week in an uncomfortable split: options traders are leaning bullish while short sellers hold a hefty 21.4% of the free float, and the stock has shed 7% in a single session to $9.89.
The positioning picture is the most interesting feature right now. Short interest has barely moved — down just 0.75% on the day and up 1% on the week to roughly 59.7 million shares, meaning shorts are not covering despite the price slide. That 21.4% of float is elevated and has been sticky, having only eased from around 66 million shares in late May. Availability remains loose at 151.6% — more shares are available to borrow than are currently shorted — so there is no squeeze pressure in the lending pool. Borrow costs have ticked up 33% on the week to 0.53%, but that is still a low absolute rate. Against this short-heavy backdrop, options positioning is telling a different story: the put/call ratio has dropped to 0.47, nearly 1.5 standard deviations below its 20-day average and close to its 52-week low of 0.46. Call demand is running unusually hot. The divergence between heavy short positioning and call-heavy options flow creates a genuine tension — two camps making opposite bets on the same stock.
The Street reflects similar uncertainty. The analyst consensus sits at Hold, with nine analysts parked at that rating. Citigroup has a Sell with a $7 target — below the current price — while B. Riley holds a Buy at $19. The mean price target is $15.36, implying meaningful upside from $9.89, but recent moves have all been in one direction. Citigroup cut its target from $9 to $7 in May. UBS trimmed from $20 to $13 in March. Goldman Sachs moved from $20 to $14 in the same week. The pattern is a steady ratchet lower. The bull case rests on NuScale's Small Modular Reactor technology and its 6 GW pipeline with the Tennessee Valley Authority. The bear case is more immediate: regulatory risk, no earnings, and a price-to-book of 1.8x on a company burning cash with a deeply negative PE. EPS momentum factor scores rank in the 93rd percentile on a 30-day basis — one of the few bright spots — but the ORTEX short score of 63.9 places SMR in a high-short-pressure cohort, and the short score rank sits in just the 5th percentile of the universe.
The institutional ownership story has one notable wrinkle. Van Eck Associates added 8.5 million shares in the period ending May 31, lifting its stake to 5.8% of shares outstanding. Mirae Asset and BlackRock also added meaningfully. But the dominant insider activity tells the opposite story: Fluor Corp, a 10% owner, sold nearly 40 million shares across three tranches in April at prices between $11.63 and $12.07 — a combined $473 million of stock dumped into a rising market. The CEO, CFO, and COO also sold in early March at around $12.22. The net insider figure looks unusual in the 90-day data because share awards inflate the gross count, but the directional message from named sellers is clear. Every significant sale happened above $11; the stock is now at $9.89.
The stock's recent earnings record adds another cautionary note. The most recent print on May 7 saw the stock fall 7.2% on the day and a further 10.8% over the following five days. The prior event in late May produced a 5.7% gain on day one but then reversed to -13.9% over the week. The next earnings are due August 7. Peers have shown mixed moves this week — NNE slipped 4.3% on the day while SES fell 7.1%, suggesting sector-wide pressure rather than an SMR-specific story.
The setup heading toward August is therefore one to watch closely: whether the call-heavy options flow reflects genuine conviction on a catalyst — perhaps a contract announcement or regulatory update on the TVA pipeline — or simply speculative positioning into a heavily shorted, low-priced name where a small move in availability or borrow costs could shift the dynamic quickly.
See the live data behind this article on ORTEX.
Open SMR on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
